Primary Record
N-acetylsphingosine
- In stock
- 8,219 g
- Purity
- 98.2 %
- CAS
- 3102-57-6
Compound Identifiers & Properties
- CAS
- 3102-57-6
- PubChem CID
- 5497136
- SMILES
- CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO)NC(=O)C)O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(C)=O
Names & Synonyms
- N-acetylsphingosine
- C2 ceramide
- C2-ceramide
- ceramide
- N-Acetyl-D-sphingosine
- Acetyl ceramide
- N-acetoyl-D-erythro-sphingosine
- C2ceramide
- 3102-57-6
- Ceramide 2
- N-(acetyl)-ceramide
- C-2 Ceramide
- C(2)-ceramide
- D-erythro-C2-Ceramide
- C2-cer
- 8YTC7R47CW
- Cer[NS]
- AC1NUZJL
- N-(acetyl)-sphing-4-enine
- UNII-8YTC7R47CW
- N-acetyldihydrosphingosine
- RefChem:917804
- C2:0 CERAMIDE
- C2 Ceramide (d18:1/2:0)
- N-acetyl-D-erythro-sphingosine
- BSPBio_001565
- C20H39NO3
- CHEBI:46979
- D-erythro-N-Acetylsphingosine
- Cer(d18:1/2:0)
- BLTCBVOJNNKFKC-QUDYQQOWSA-N
- D-erythro-N-acetyl-sphingosine
- D-erythro-Sphingosine, N-Acetyl-
- BML3-C10
- CHEMBL105867
- DTXSID201016802
- orb1704630
- SCHEMBL1191825
- CHEBI:92736
- N-ACETYL-C18-SPHINGOSINE
- MFCD00153903
- DTXCID401474997
- HMS1361O07
- HMS1791O07
- HMS1989O07
- HMS3402O07
- HMS3411F19
- HMS3649E05
- HMS3675F19
- HMS6018C06
- ZINC8830550
- 1646AH
- C20-H39-N-O3
- CMC_12038
- CMC_12046
- CMC_12047
- HSCI1_000073
- LMSP02010014
- 195194-58-2
- AKOS015915613
- CID5497136
- EBD2217018
- FC19605
- CID:5497136
- IDI1_034035
- NCGC00024763-03
- BP-42426
- DA-61978
- MS-25224
- N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide
- SID:53787625
- HY-101180
- J640.711K
- J853.911A
- LS-186922
- LS-187572
- CS-0020949
- FT-0623355
- G13400
- N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide
- C064769
- N-[(2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide
- SR-01000597683
- SR-01000946564
- (2S,3R)-2-(Acetylamino)-4-octadecene-1,3-diol
- A1202526
- N-((2S,3R,E)-1,3-Dihydroxyoctadec-4-en-2-yl)acetamide
- SR-01000597683-1
- SR-01000946564-1
- (2S,3R,4E)-2-(Acetylamino)-4-octadecene-1,3-diol
- BRD-K41707108-001-02-3
- BRD-K41707108-001-03-1
- BRD-K41707108-001-05-6
- I14-53272
- Q27120742
- D-erythro-1,3-Dihydroxy-2-acetamido-trans-4-octadecene
- Acetamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R*,S*-(E)))-
- ACETAMIDE,N-[20-(FORMYLAMINO)PREGN-5-EN-3- YL]-
- N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]acetamide
- C2 Ceramide (d18:1/2:0), N-acetoyl-D-erythro-sphingosine, powder
- N-[(E,1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadec-3-enyl]acetamide
- acetamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-
- Acetamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-
- N-((1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl)acetamide
- N-[(1S,2R)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]acetamide
- ACETAMIDE, N-((1S,2R,3E)-2-HYDROXY-1-(HYDROXYMETHYL)-3-HEPTADECEN-1-YL)-
- Acetamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R*,S*))-
- Acetamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]- (9CI)
- Acetamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, (E)-D-erythro- (8CI)
- Acetamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]-
- 125187-53-3